News
Oxford Nanopore Technologies and Cyclomics begin developer testing on non-invasive method for accurate and fast detection of molecules associated with cancer
Research collaboration has resulted in new ‘liquid biopsy’ research workflow using nanopore sequencing to detect molecules that are associated with cancer, circulating in blood
Cyclomics announces completion of seed financing round
Venture Challenge alumnus Cyclomics has completed a financing round driven by a group of private investors too accelerate the development of innovate technologies in the field of cancer genetic testing.
Meet the teams of the Proefdiervrij Venture Challenge 2023
Today the special Proefdiervrij (animal-free) edition of the Venture Challenge has started. In this Venture Challenge four teams participate with innovations that have the potential to reduce or replace animal testing.
Movax Biopharma wins 35.000 AtlasInvest Entrepreneurship Grant
Start-ups that win an AtlasInvest Entrepreneurship Grant can use the money to set up their own lab or expand their business, for example.
Venture Challenge Alumnus of 2010 NTRC Therapeutics closes deal with Symeres and sells CRO division Oncolines B.V
Oncolines B.V., the CRO division of NTRC B.V. has been acquired by Symeres. NTRC Therapeutics participated in the Venture Challenge of 2010. The team consisted of Guido Zaman and Rogier Buijsman.
Venture Challenge Alumnus Autosciber closes 1,2 Million Euro Seed round
Venture Challenge Alumnus Autoscriber, an AI-based voice recognition software that captures and summarises consultations between healthcare professionals and patients, has closed its Seed round at €1.2M.
Protinhi Therapeutics successful in EIC Accelerator
Venture Challenge alumnus Prothinhi Therapeutics was one of the 11 Dutch companies that were successful in the latest EIC Accelerator round, together they raised €77mln.
Expert Class on reimbursement very insightful
At the final expert class of 2022 we were happy to welcome a large group of startups that were keen to learn all about reimbursement.
Venture Challenge wins prestigious European Award
The lifesciences@work Venture Challenge has won the European Enterprise Promotion Award 2022 (EEPA) in the category ‘Improving the Business Environment and Supporting the Digital Transition’. We - Chrétien Herben and Simone Hermans - were invited to the EEPA finals in Prague after winning the National EEPA round in June of this year.
PrecorDx Wins the Venture Challenge Fall 2022!
The winner of the Venture Challenge was announced today at the Dutch Life Sciences Conference. The proud winner of the 2022 fall edition is PrecorDx! The innovative startup PrecorDx has developed a non-invasive diagnostic platform aimed at reducing hospitalization & slowing disease progression in heart failure.